| Literature DB >> 33230760 |
Gabriel Plitzko1, Grégoire Schmutz1, Dino Kröll1, Philipp C Nett1, Yves Borbély2.
Abstract
Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication of Helicobacter pylori and secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose.Entities:
Keywords: Anti-inflammatory agents; Gastric remnant; Gastritis; Gastrostomy; Hemorrhage; Morbid obesity; Non-steroidal anti-inflammatory drugs; Peptic ulcer perforation; Roux-Y gastric bypass
Mesh:
Year: 2020 PMID: 33230760 PMCID: PMC7921036 DOI: 10.1007/s11695-020-05123-w
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 4.129